|
Oct 5
|
Editas Medicine Secures $57M Deal for Gene-Editing Technology
|
|
Oct 4
|
Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m
|
|
Oct 4
|
National Bank on DRI Healthcare's Casgevy Stream Acquisition
|
|
Oct 4
|
Editas trades Vertex fees for upfront cash in DRI deal
|
|
Oct 4
|
DRI Healthcare Trust Buying Payment Streams Based On Gene-Editing Technology For US$57 Million
|
|
Oct 3
|
Editas Medicine Announces $50+ Million Monetization Financing with DRI Healthcare Trust
|
|
Sep 6
|
Editas (EDIT) Down 17% Since Last Earnings Report: Can It Rebound?
|
|
Jun 27
|
What Makes Editas Medicine, Inc. (EDIT) One of the Best Small-Cap Stocks with Highest Upside Potential?
|
|
Jun 17
|
Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
|
|
Jun 14
|
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual Congress
|
|
Jun 14
|
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual Congress
|
|
May 14
|
Director Jessica Hopfield Acquires 45,000 Shares of Editas Medicine Inc (EDIT)
|
|
May 14
|
Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June
|
|
May 12
|
Editas Medicine, Inc. (NASDAQ:EDIT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
|
|
May 10
|
Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting
|
|
May 9
|
Editas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript
|
|
May 9
|
1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15. Is It a Buy Around $5?
|
|
May 9
|
Editas (EDIT) Q1 Earnings & Revenues Lag Estimates, Stock Down
|
|
May 9
|
Editas Medicine First Quarter 2024 Earnings: Misses Expectations
|
|
May 9
|
Q1 2024 Editas Medicine Inc Earnings Call
|